Discovery of secondary sulphonamides as IDO1 inhibitors with potent antitumour effects in vivo

Indoleamine 2,3-dioxygenase 1 (IDO1) as a key rate-limiting enzyme in the kynurenine pathway of tryptophan metabolism plays an important role in tumour immune escape. Herein, a variety of secondary sulphonamides were synthesised and evaluated in the HeLa cell-based IDO1/kynurenine assay, leading to...

Descripción completa

Detalles Bibliográficos
Autores principales: Ge, Shushan, Zhong, Haiqing, Ma, Xuewei, Zheng, Yingbo, Zou, Yi, Wang, Fang, Wang, Yan, Hu, Yue, Li, Yuezhen, Liu, Wen, Guo, Wenjie, Xu, Qiang, Lai, Yisheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336998/
https://www.ncbi.nlm.nih.gov/pubmed/32466694
http://dx.doi.org/10.1080/14756366.2020.1765165

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336998/
https://www.ncbi.nlm.nih.gov/pubmed/32466694
http://dx.doi.org/10.1080/14756366.2020.1765165

Ejemplares similares